These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Plasma levels of maprotiline and zimelidine and their relationship to clinical response in depressed patients. Hrdina PD; Lapierre YD Ther Drug Monit; 1986; 8(4):400-6. PubMed ID: 2950616 [TBL] [Abstract][Full Text] [Related]
48. [Clinical considerations regarding the use of maprotiline in psychiatric treatment]. Pirozynski T; Chiriţă V; Mungiu OC; Cosmovici N; Boişteanu P Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):251-5. PubMed ID: 3685686 [No Abstract] [Full Text] [Related]
49. Plasma 3,4-dihydroxyphenylethyleneglycol and therapeutic response to maprotiline and indalpine in major depression. Lôo H; Benkelfat C; Poirier MF; Vanelle JM; Olié JP; Dennis T; Scatton B Neuropsychobiology; 1986; 15(2):62-7. PubMed ID: 3762900 [TBL] [Abstract][Full Text] [Related]
50. Studies on 3-methoxy-4-hydroxyphenylglycol (MHPG) and 3,4-dihydroxyphenylglycol (DHPG) levels in human urine, plasma and cerebrospinal fluids, and their significance in studies of depression. Tsuji M; Yamane H; Yamada N; Iida H; Taga C; Myojin T Jpn J Psychiatry Neurol; 1986 Mar; 40(1):47-56. PubMed ID: 3773351 [TBL] [Abstract][Full Text] [Related]
51. 3-MHPG as a non-predictor of antidepressant response to imipramine and electroconvulsive therapy. Sharma IJ; Venkitasubramanian TA; Agnihotri BR Acta Psychiatr Scand; 1986 Sep; 74(3):252-4. PubMed ID: 3788651 [TBL] [Abstract][Full Text] [Related]
52. Urinary MHPG and ward behavior in unmedicated psychiatric patients. Mueser KT; Rosen AJ; Dysken MW; Javaid JI Psychiatry Res; 1983 Dec; 10(4):275-83. PubMed ID: 6583716 [TBL] [Abstract][Full Text] [Related]
54. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients. Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439 [TBL] [Abstract][Full Text] [Related]
55. EEG characteristics of clinically defined on-drug-responders and non-responders--a comparison clomipramine vs. maprotiline. Ulrich G; Haug HJ; Stieglitz RD; Fähndrich E Pharmacopsychiatry; 1988 Nov; 21(6):367-8. PubMed ID: 3244769 [No Abstract] [Full Text] [Related]
56. Does 24-h urinary MHPG predict treatment response to antidepressants? II. Association between imipramine response and low MHPG. Garvey M; DeRubeis RJ; Hollon SD; Evans MD; Tuason VB J Affect Disord; 1990 Nov; 20(3):181-4. PubMed ID: 2148338 [TBL] [Abstract][Full Text] [Related]
57. Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings. Muscettola G; Potter WZ; Pickar D; Goodwin FK Arch Gen Psychiatry; 1984 Apr; 41(4):337-42. PubMed ID: 6703853 [TBL] [Abstract][Full Text] [Related]
58. Failure to correlate urinary MHPG with clinical response to amitriptyline. Puzynski S; Rode A; Bidzinski A; Mrozek S; Zaluska M Acta Psychiatr Scand; 1984 Feb; 69(2):117-20. PubMed ID: 6702474 [TBL] [Abstract][Full Text] [Related]
59. Lack of correlation between DST results and urinary MHPG in depressed inpatients. Lôo H; Poirier MF; Dennis T; Benkelfat C; Vanelle JM; Gay C; Galinowski A; Askienazy S; Scatton B J Neural Transm; 1988; 72(2):121-30. PubMed ID: 3385423 [TBL] [Abstract][Full Text] [Related]
60. MHPG excretion in depressive disorders: relation to clinical subtypes and desynchronized sleep. Schildkraut JJ; Keeler BA; Papousek M; Hartmann E Science; 1973 Aug; 181(4101):762-4. PubMed ID: 4353428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]